HUDSONALPHA INST FOR BIOTECHNOLOGY has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, machines and measurement are ULITZUR SHIMON, ORITEST SRO and BIOLYTIX AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Israel | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Machines | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms | |
#3 | Fermentation | |
#4 | Unspecified technologies | |
#5 | Peptides | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Myers Richard M | 12 |
#2 | Roberts Brian S | 6 |
#3 | Brooks James D | 6 |
#4 | Kirby Marie K | 5 |
#5 | Han Jian | 3 |
#6 | Richard M Myers | 2 |
#7 | Brian S Roberts | 2 |
#8 | Absher Devin | 1 |
#9 | Varley Katherine E | 1 |
#10 | Kirby Marie | 1 |
Publication | Filing date | Title |
---|---|---|
US2019375806A1 | Method of treating breast cancer | |
US2018073066A1 | Method for blocking miRNA | |
WO2015120142A2 | Differential methylation level of cpg loci that are determinative of kidney cancer | |
EP3498862A2 | Differential methylation level of cpg loci that are determinative of a biochemical reoccurrence of prostate cancer | |
EP2281065A2 | Method for evaluating and comparing immunorepertoires |